Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Diabetes Care
Liana K BillingsEsteban Jódar

Abstract

In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin may be initiated. We assessed the efficacy and safety of initiating insulin degludec/liraglutide fixed-ratio combination (IDegLira) versus basal-bolus insulin. A phase 3b trial examined patients with uncontrolled type 2 diabetes on insulin glargine (IGlar U100) 20-50 units/day and metformin, randomized to IDegLira or IGlar U100 and insulin aspart ≤4 times per day. Glycated hemoglobin (HbA1c) decreased from 8.2% (66 mmol/mol) to 6.7% (50 mmol/mol) with IDegLira and from 8.2% (67 mmol/mol) to 6.7% (50 mmol/mol) with basal-bolus (estimated treatment difference [ETD] -0.02% [95% CI -0.16, 0.12]; -0.2 mmol/mol [95% CI -1.7, 1.3]), confirming IDegLira noninferiority versus basal-bolus (P < 0.0001). The number of severe or blood glucose-confirmed symptomatic hypoglycemia events was lower with IDegLira versus basal-bolus (risk ratio 0.39 [95% CI 0.29, 0.51]; rate ratio 0.11 [95% CI 0.08, 0.17]). Body weight decreased with IDegLira and increased with basal-bolus (ETD -3.6 kg [95% CI -4.2, -2.9]). Fasting plasma glucose reductions were similar; lunch, dinner, and bedtime self-monitored plasma glucose measurements were significantly lower with basal-bolus. Si...Continue Reading

References

Dec 8, 2010·Metabolism: Clinical and Experimental·Ebenezer A NyenweAbbas E Kitabchi
Jan 25, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·B T BlakT Ivanyi
Feb 9, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotP-M Schumm-Draeger
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Apr 29, 2014·The Journal of the American Osteopathic Association·Etie S Moghissi
Aug 13, 2014·Diabetes Care·John B BuseUNKNOWN NN9068-3912 (DUAL-II) Trial Investigators
Sep 3, 2014·Clinical Pharmacokinetics·Hanne Haahr, Tim Heise
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Sep 3, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·H W RodbardUNKNOWN Dual Action of Liraglutide and insulin degludec (DUAL) IV trial investigators
Oct 12, 2016·Primary Care Diabetes·Kamlesh Khunti, David Millar-Jones
Dec 17, 2016·Diabetes Care
Jun 13, 2017·The New England Journal of Medicine·Steven P MarsoUNKNOWN DEVOTE Study Group

❮ Previous
Next ❯

Citations

May 1, 2018·Diabetes, Obesity & Metabolism·Ronald M GoldenbergJean-François Yale
Jun 7, 2018·Diabetes Technology & Therapeutics·Robert E Ratner
Oct 12, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michael DempseyBarnaby Hunt
Nov 2, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Ildiko LingvayAndreas Liebl
Jul 10, 2019·Diabetes, Obesity & Metabolism·Cees J TackUNKNOWN LEADER Publication Committee on behalf of the LEADER Trial Investigators
Nov 5, 2019·Annals of Internal Medicine·Sandeep Vijan
Dec 27, 2019·American Journal of Therapeutics·Helena W Rodbard, David Rodbard
Dec 7, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Cheli Melzer-CohenAvraham Karasik
Nov 25, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Hirotaka WatadaLiana K Billings
Jun 27, 2018·BMJ Open Diabetes Research & Care·Russell DrummondBengt-Olov Tengmark
Jan 6, 2019·Advances in Therapy·Leigh PerreaultEric Johnson
Mar 5, 2019·Journal of the Royal Statistical Society. Series A, (Statistics in Society)·Suzie CroMichael G Kenward
Nov 7, 2019·Diabetes Technology & Therapeutics·Christopher G ParkinRolf Hinzmann
Jul 28, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Zoltán TaybaniTamás Várkonyi
Jul 4, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Björn EliassonAnn-Marie Svensson
Apr 11, 2018·Diabetology & Metabolic Syndrome·Rodrigo Oliveira MoreiraRaquel C Lopes Assis Coelho
Jul 17, 2019·Pharmaceutical Statistics·Andrew AtkinsonJames R Carpenter
Jun 9, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Leonard E EgedeLee Kallenbach
Feb 2, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Johannes PöhlmannBarnaby Hunt
Oct 27, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Luciano ZenariAnnunziata Lapolla
Nov 29, 2020·The Journal of Clinical Endocrinology and Metabolism·Giovana F PiccoliFernando Gerchman
Nov 16, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Nov 17, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rainer U PliquettMatthias Girndt

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.